4//SEC Filing
Hirsch Daniel J. 4
Accession 0001062993-23-018934
CIK 0001840877other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 9:46 PM ET
Size
7.4 KB
Accession
0001062993-23-018934
Insider Transaction Report
Form 4
Hirsch Daniel J.
DirectorCFO and Corporate Secretary
Transactions
- Conversion
Class B Common Stock, par value $0.0001 per share
2023-09-29−25,000→ 0 total→ Class A Common Stock, par value $0.0001 per share (25,000 underlying) - Conversion
Class A Common Stock, par value $0.0001 per share
2023-09-29+25,000→ 25,000 total
Footnotes (1)
- [F1]On September 29, 2023, in connection with the consummation of the business combination (the "Business Combination") between Anzu Special Acquisition Corp I ("Anzu") and Envoy Medical Corporation, each share of Class B Common Stock, par value $0.0001 per share, automatically converted into one share of Class A Common Stock, par value $0.0001 per share. In connection with the Business Combination, Mr. Hirsch resigned as Chief Financial Officer, Corporate Secretary, and Director of Anzu.
Issuer
Envoy Medical, Inc.
CIK 0001840877
Entity typeother
Related Parties
1- filerCIK 0001453077
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 9:46 PM ET
- Size
- 7.4 KB